Search Results

There are 4082 results for: content related to: Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

  1. You have free access to this content
    Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 283–291, Andrea G Ludolph, Patrick T Udvardi, Ulrike Schaz, Carolin Henes, Oliver Adolph, Henry U Weigt, Joerg M Fegert, Tobias M Boeckers and Karl J Föhr

    Version of Record online : 2 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00707.x

  2. You have free access to this content
    Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents

    British Journal of Pharmacology

    Volume 156, Issue 2, January 2009, Pages: 226–236, Daniel Scherer, David Hassel, Ramona Bloehs, Edgar Zitron, Katharina Von Löwenstern, Claudia Seyler, Dierk Thomas, Franziska Konrad, Heiner F. Bürgers, Gunnar Seemann, Wolfgang Rottbauer, Hugo A. Katus, Christoph A. Karle and Eberhard P. Scholz

    Version of Record online : 19 JAN 2009, DOI: 10.1111/j.1476-5381.2008.00018.x

  3. Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making

    Addiction Biology

    Volume 20, Issue 4, July 2015, Pages: 714–723, Nienke Broos, Rhianne Loonstra, Yvar van Mourik, Dustin Schetters, Anton N. M. Schoffelmeer, Tommy Pattij and Taco J. De Vries

    Version of Record online : 23 JUL 2014, DOI: 10.1111/adb.12168

  4. Long-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder

    Asia-Pacific Psychiatry

    Volume 6, Issue 3, September 2014, Pages: 292–301, Yuko Hirata, Taro Goto, Yasushi Takita, Paula T Trzepacz, Albert J Allen, Hironobu Ichikawa and Michihiro Takahashi

    Version of Record online : 25 DEC 2013, DOI: 10.1111/appy.12119

  5. Pharmacokinetics, Safety, and Tolerability of Atomoxetine and Effect of CYP2D6*10/*10 Genotype in Healthy Japanese Men

    The Journal of Clinical Pharmacology

    Volume 52, Issue 3, March 2012, Pages: 388–403, Dr A. Matsui, Dr J. Azuma, Dr J. W. Witcher, Ms A. J. Long, Dr J.-M. Sauer, Dr B. P. Smith, Dr K. A. DeSante, Dr H. A. Read, Dr M. Takahashi and Dr M. Nakano

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011398657

  6. Targeting presynaptic norepinephrine transporter in brown adipose tissue: A novel imaging approach and potential treatment for diabetes and obesity

    Synapse

    Volume 67, Issue 2, February 2013, Pages: 79–93, M. Reza Mirbolooki, Cristian C. Constantinescu, Min-Liang Pan and Jogeshwar Mukherjee

    Version of Record online : 8 NOV 2012, DOI: 10.1002/syn.21617

  7. You have full text access to this OnlineOpen article
    Atomoxetine Increased Effect over Time in Adults with Attention-Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double-Blind, Placebo-Controlled, Randomized Trials

    CNS Neuroscience & Therapeutics

    Volume 22, Issue 7, July 2016, Pages: 546–557, Linda A. Wietecha, David B. Clemow, Andrew S. Buchanan, Joel L. Young, Elias H. Sarkis and Robert L. Findling

    Version of Record online : 28 FEB 2016, DOI: 10.1111/cns.12533

  8. Hemodynamic Effects of Acute Administration of Atomoxetine and Methylphenidate

    The Journal of Clinical Pharmacology

    Volume 45, Issue 7, July 2005, Pages: 851–855, Dr Ronan P. Kelly, Dr Kwee Poo Yeo, Dr Choo-Hua Teng, Dr Brian P. Smith, Dr Stephen Lowe, Dr Danny Soon, Dr Holly A. Read and Dr Stephen D. Wise

    Version of Record online : 25 MAR 2013, DOI: 10.1177/0091270005276737

  9. A cohort study of the risk of seizures in a pediatric population treated with atomoxetine or stimulant medications

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 4, April 2013, Pages: 386–393, Andrew T. McAfee, Joan Landon, Meghan Jones, Mark E. Bangs, Nayan Acharya, Ken Hornbuckle and Judy Wong

    Version of Record online : 26 DEC 2012, DOI: 10.1002/pds.3390

  10. You have free access to this content
    Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice

    Journal of Neurochemistry

    Volume 114, Issue 1, July 2010, Pages: 259–270, Ken Koda, Yukio Ago, Yana Cong, Yuki Kita, Kazuhiro Takuma and Toshio Matsuda

    Version of Record online : 16 APR 2010, DOI: 10.1111/j.1471-4159.2010.06750.x

  11. Neural correlates of atomoxetine improving inhibitory control and visual processing in Drug-naïve adults with attention-deficit/hyperactivity disorder

    Human Brain Mapping

    Volume 38, Issue 10, October 2017, Pages: 4850–4864, Li-Ying Fan, Tai-Li Chou and Susan Shur-Fen Gau

    Version of Record online : 28 JUN 2017, DOI: 10.1002/hbm.23683

  12. A liquid chromatography/tandem mass spectrometry assay for the analysis of atomoxetine in human plasma and in vitro cellular samples

    Biomedical Chromatography

    Volume 26, Issue 11, November 2012, Pages: 1364–1370, David I. Appel, Bryan Brinda, John S. Markowitz, Jeffrey H. Newcorn and Hao-Jie Zhu

    Version of Record online : 25 JAN 2012, DOI: 10.1002/bmc.2706

  13. You have free access to this content
    A Modeled Economic Evaluation Comparing Atomoxetine with Stimulant Therapy in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

    Value in Health

    Volume 11, Issue 3, May/June 2008, Pages: 376–388, Suzi Cottrell, Dominic Tilden, Paul Robinson, Jay Bae, Jorge Arellano, Eric Edgell, Mike Aristides and Kristina S. Boye

    Version of Record online : 4 SEP 2007, DOI: 10.1111/j.1524-4733.2007.00256.x

  14. Kinetic modeling and occupancy measures of the norepinephrine transporters in baboons using single photon emission computed tomography with 123I-INER

    Synapse

    Volume 67, Issue 1, January 2013, Pages: 30–41, Adriana Alexandre Dos Santos Tavares, Olivier Barret, Jeffery Batis, David Alagille, Andrei Koren, Caroline Papin, Greg Kudej, Katie Nice, Jeffrey H. Kordower, Kelly P. Cosgrove, Tracy Kloczynski, Eric Brenner, John Seibyl and Gilles Tamagnan

    Version of Record online : 31 OCT 2012, DOI: 10.1002/syn.21613

  15. Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder

    Asia-Pacific Psychiatry

    Volume 6, Issue 4, December 2014, Pages: 386–396, Soyoung Irene Lee, Dong-Ho Song, Dong Won Shin, Ji Hoon Kim, Young Sik Lee, Jun-Won Hwang, Tae Won Park, Ki-Hwan Yook, Jong Il Lee, Geon Ho Bahn, Yuko Hirata, Taro Goto, Yasushi Takita, Michihiro Takahashi, Sanghoon Lee and Tamás Treuer

    Version of Record online : 27 OCT 2014, DOI: 10.1111/appy.12160

  16. Atomoxetine for Orthostatic Hypotension in an Elderly Patient Over 10 Weeks: A Case Report

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 9, September 2015, Pages: e141–e148, Genevieve M. Hale and Michael Brenner

    Version of Record online : 25 SEP 2015, DOI: 10.1002/phar.1635

  17. You have free access to this content
    Atomoxetine pharmacokinetics in healthy Chinese subjects and effect of the CYP2D6*10 allele

    British Journal of Clinical Pharmacology

    Volume 64, Issue 4, October 2007, Pages: 445–449, Yi M. Cui, Choo H. Teng, Alan X. Pan, Eunice Yuen, Kwee P. Yeo, Ying Zhou, Xia Zhao, Amanda J. Long, Mark E. Bangs and Stephen D. Wise

    Version of Record online : 4 JUL 2007, DOI: 10.1111/j.1365-2125.2007.02912.x

  18. Safety of non-therapeutic atomoxetine exposures—a national poison data system study

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 5, September 2013, Pages: 471–476, Andrew A. Monte, Alessandro Ceschi and Michael Bodmer

    Version of Record online : 17 JUL 2013, DOI: 10.1002/hup.2334

  19. Retrospective Safety Analysis of Atomoxetine in Adult ADHD Patients with or without Comorbid Alcohol Abuse and Dependence

    The American Journal on Addictions

    Volume 18, Issue 5, September-October 2009, Pages: 393–401, Lenard Adler, Timothy Wilens, Shuyu Zhang, Todd Durell, Daniel Walker, Leslie Schuh, Ling Jin, Peter Feldman and Paula Trzepacz

    Version of Record online : 18 FEB 2010, DOI: 10.1080/10550490903077663

  20. Predictors of pharmacological treatment outcomes with atomoxetine or methylphenidate in patients with attention-deficit/hyperactivity disorder from China, Egypt, Lebanon, Russian Federation, Taiwan, and United Arab Emirates

    International Journal of Clinical Practice

    Volume 68, Issue 9, September 2014, Pages: 1152–1160, T. Treuer, Q. Feng, D. Desaiah, M. Altin, S. Wu, A. El-Shafei, E. Serebryakova, M. Gado and D. Faries

    Version of Record online : 6 APR 2014, DOI: 10.1111/ijcp.12437